Form 4: Intuitive Surgical Director Mark Rubash Executes Stock Option and Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Director Mark Rubash exercised stock options and sold shares of Intuitive Surgical (ISRG) under a pre-arranged 10b5-1 trading plan.
Summary
- On May 3, 2024, Mark Rubash, a director of Intuitive Surgical Inc. (ISRG), executed a transaction involving the company's stock.
- Rubash exercised non-qualified stock options to acquire 1,709 shares of common stock at an exercise price of $295.92.
- Simultaneously, Rubash sold 1,709 shares of common stock at a price of $380.
- These transactions were conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1, set to expire on February 3, 2025.
- Following these transactions, Rubash directly owns 16,051 shares of Intuitive Surgical.
- The stock options were granted with a vesting schedule of 100% vesting on the earlier of one year from the grant date or the next Annual Meeting of Stockholders, contingent upon continued service as a director.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine execution of a pre-planned stock sale under a 10b5-1 trading plan. It doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of 10b5-1 trading plans allows insiders to sell shares over a period of time, mitigating concerns about insider trading. These transactions are closely watched by investors for insights into management's perspective on the company's value and future prospects. Competitors in the robotic surgery space, such as Medtronic and Stryker, also see similar insider trading activity.
Comparison to Industry Standards
- Executive compensation and stock option plans are standard practice among publicly traded companies, including Intuitive Surgical's competitors like Medtronic and Stryker.
- The vesting schedule of the options, with full vesting within one year or at the next annual meeting, is fairly typical.
- The use of a 10b5-1 trading plan is a common method for executives to manage their stock holdings while avoiding insider trading accusations, aligning with practices seen at comparable companies.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- Shareholders may view the transaction as a routine event under a pre-arranged trading plan.
- Employees are unlikely to be directly affected by this transaction.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Date of stock option exercise and share sale. |
| 02/03/2025 | Expiration date of the 10b5-1 trading plan. |
| 04/26/2030 | Expiration date of the Non-Qualified Stock Option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.